MA

Mohammed Asifoddin

Active Director Director DIN 10742322
DIN 10742322 First appointment Aug 2024 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Mohammed Asifoddin

Data last updated:

Mohammed Asifoddin is a Director at Muran Pharma Private Limited (since 2024). The company operates in Healthcare.

DIN 10742322
Primary Designation Director
Industry Healthcare
First Appointment 13 Aug 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Muran Pharma Private Limited U47721TS2024PTC188500
Director13 Aug 20242024Active

Board colleagues of Mohammed Asifoddin

NameDINCompanyDesignation
Syed Muqtar10742321Muran Pharma Private LimitedDirector
Syed Nisar Ahmed10742320Muran Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Muran Pharma Private Limited
Premium access

Shareholding and investment profile for Mohammed Asifoddin

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohammed Asifoddin

Mohammed Asifoddin currently holds 1 directorship: Muran Pharma Private Limited (Director, since 13 Aug 2024).

Mohammed Asifoddin was first appointed on 13 Aug 2024 as Director at Muran Pharma Private Limited.

The current boards of Mohammed Asifoddin's companies include Syed Muqtar (Muran Pharma Private Limited), Syed Nisar Ahmed (Muran Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available